| Course | NR 568 Advanced Pharmacology for the Adult-Gerontology Primary Care Nurse Practitioner |
|---|---|
| Week | 6 |
| Paper type | Adverse effect write-up |
| Length | About 1,160 words, 5 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | MSN, Adult-Gerontology Primary Care NP (AGPCNP) |
| Updated | October 2026 |
Free sample paper for NR 568 Week 6
Adverse Effect Write-Up: A Sodium of 126 and New Confusion Six Weeks After Chlorthalidone Was Raised, Traced to a Drug Already Prescribed and Handled Without Leaving the Blood Pressure Untreated
Student Name
College of Nursing, Chamberlain University
NR 568: Advanced Pharmacology for the Adult-Gerontology Primary Care Nurse Practitioner
Instructor Name
Month Day, Year
Adverse Effect Write-Up: A Sodium of 126 and New Confusion Six Weeks After Chlorthalidone Was Raised, Traced to a Drug Already Prescribed and Handled Without Leaving the Blood Pressure Untreated
The Event
In late November, the patient's spouse called the practice to say that the patient had been confused for two days, could not follow a television program and had nearly fallen in the kitchen. At a same-day visit, the patient was alert but disoriented to date, with no focal neurological signs. Serum sodium was 126 mmol/L, compared with 137 mmol/L in August. Potassium was 3.3 mmol/L. Glucose, calcium and thyroid tests were normal. Urine osmolality was inappropriately concentrated, consistent with impaired water excretion.
The Interval, Stated
The interval is the key fact. Chlorthalidone was increased from 12.5 mg to 25 mg on 7 October, when doxazosin was being tapered and the blood pressure was expected to rise. The confusion began on 20 November, about six weeks later. Thiazide-associated hyponatremia usually develops within the first weeks after starting or increasing the dose, though it can appear later, and older age, female sex, low body weight and other drugs that affect sodium increase the risk (Leung et al., 2011). A six-week interval fits that pattern.
The other candidate is citalopram, a selective serotonin reuptake inhibitor that can make the body hold on to water by raising antidiuretic hormone activity. But citalopram was reduced from 40 mg to 20 mg in September, not increased, and the patient has taken it for six years without hyponatremia. Antidepressant-associated hyponatremia is most common in the first weeks of treatment (Leth-Møller et al., 2016). The timing therefore points to chlorthalidone, with citalopram as a contributing background factor.
Does It Track the Dose?
The effect tracks the dose. The patient took chlorthalidone 12.5 mg for two years with sodium values between 135 and 139 mmol/L. The sodium fell only after the dose doubled. Thiazide effects on sodium and potassium are dose-related, and the potassium fell at the same time, which supports a diuretic cause.
Other Causes Considered
The write-up does not argue about alternatives at length, but it records that they were checked: no vomiting, diarrhea or new fluid intake pattern; no new medicines besides the chlorthalidone change; normal glucose and thyroid function; no signs of heart failure or liver disease. The patient had started drinking more water in October on advice to prevent dizziness, which could add to the problem by increasing free water intake while the kidney's ability to excrete it was impaired.
What Actually Came Off
Chlorthalidone was stopped on 22 November. Because the sodium was 126 with moderate symptoms, the patient was admitted overnight for monitoring, fluid restriction to 1 liter a day and potassium replacement. Sodium rose to 131 the next day and 134 by day three, a rate of correction within safe limits. The patient's confusion cleared by the second day. Citalopram was continued at 20 mg, with a sodium check planned, because stopping it as well would make it impossible to know which drug was responsible and would risk a relapse of depression.
The Condition Left Behind
Removing chlorthalidone left the blood pressure less controlled, with sitting readings around 148/84 a week later. The condition it treated cannot simply be left. Amlodipine 2.5 mg daily was started, a calcium channel blocker that does not affect sodium, with a plan to increase to 5 mg in four weeks if needed. The patient's lisinopril 40 mg continued. Amlodipine can cause ankle swelling, which is a known effect and should not lead to a diuretic being added back, a prescribing cascade the practice will watch for.
What the Patient Was Told
The patient and spouse were told that the water pill had lowered the salt in the blood, causing the confusion; that it has been stopped permanently and should be recorded as an intolerance; that a different blood pressure pill has replaced it; and that drinking large amounts of water is no longer advised. They were told to call for any return of confusion, headache, nausea or unsteadiness.
Lessons for the Practice
Two lessons follow from the event. First, a thiazide dose was raised in a 79-year-old, low-weight patient already taking a selective serotonin reuptake inhibitor, without a sodium check scheduled in the following weeks. Both drugs are known to lower sodium, and the combination raises the risk. Second, the advice to drink more water for dizziness, given informally, added free water at the same time. The practice has added a standing order for sodium and potassium two to four weeks after any thiazide start or increase in patients over 75, and a reminder that advice about fluid intake should be checked against the medication list.
Why Chlorthalidone Is Not Restarted at a Lower Dose
Restarting chlorthalidone at 12.5 mg was considered, since the patient tolerated that dose for two years. It was rejected because the patient's age, weight and citalopram make recurrence likely, and amlodipine provides an alternative that does not affect sodium. Rechallenge after a hospital admission for hyponatremia would need a strong reason, and none exists here.
Monitoring
Sodium and potassium at one week and four weeks after discharge, and again if any new drug affecting sodium is considered. Home blood pressure twice daily for two weeks.
How the Practice Will Recognize It Next Time
The episode is added to the practice's teaching file as an example of a common, preventable reaction. Hyponatremia in older adults often presents as confusion, unsteadiness or falls rather than as anything that points to the kidney, and it is easily attributed to dementia or to a new infection. Checking sodium in any older patient on a thiazide or a selective serotonin reuptake inhibitor who becomes confused is a simple rule that would have shortened this patient's two days of confusion. The practice nurse who took the spouse's call is commended for arranging a same-day visit rather than waiting.
Reportable or Not
The event is a serious adverse drug reaction because it led to hospital admission, and the geriatric prescribing criteria already flag both diuretics and serotonin reuptake inhibitors as drugs to use with caution because of sodium (American Geriatrics Society Beers Criteria Update Expert Panel, 2023). It was entered in the patient's allergy and intolerance record as chlorthalidone, hyponatremia, and reported to the Food and Drug Administration's MedWatch program by the practice, as hospital admissions from known drug effects are still useful for surveillance. The case was also reviewed at the practice's monthly safety meeting to consider sodium checks two to four weeks after any thiazide dose increase in patients over 75.
References
American Geriatrics Society Beers Criteria Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052-2081. https://doi.org/10.1111/jgs.18372
Leth-Møller, K. B., Hansen, A. H., Torstensson, M., Andersen, S. E., Ødum, L., Gislasson, G., Torp-Pedersen, C., & Holm, E. A. (2016). Antidepressants and the risk of hyponatremia: A Danish register-based population study. BMJ Open, 6(5), e011200. https://doi.org/10.1136/bmjopen-2016-011200
Leung, A. A., Wright, A., Pazo, V., Karson, A., & Bates, D. W. (2011). Risk of thiazide-induced hyponatremia in patients with hypertension. The American Journal of Medicine, 124(11), 1064-1072. https://doi.org/10.1016/j.amjmed.2011.06.031
Reading the NR 568 Week 6 instructions
The adverse effect write-up usually asks you to analyze a new symptom that may be caused by a prescribed drug. Expect the prompt to ask about timing, causation, management and reporting. State the interval between starting or changing the drug and the onset of the problem, and compare it with what the drug is known to do. Check whether the effect changed with the dose. Record which drug actually came off and what replaced it, because the condition it treated still needs care. Note the other causes you checked without turning the paper into a debate. Explain what the patient was told, set monitoring and say whether the event is reportable and to whom.
Inside the NR 568 Week 6 example
The sample describes the spouse's call, the visit and laboratory results showing a sodium of 126 and potassium of 3.3. It fixes the interval: chlorthalidone doubled on 7 October and confusion from 20 November, consistent with the known pattern of thiazide-associated hyponatremia. Citalopram is weighed and judged a background factor because its dose had fallen. Dose tracking, other causes and increased water intake are recorded. Chlorthalidone stops, the patient is admitted overnight and sodium is corrected safely while citalopram continues. Amlodipine replaces the thiazide, with a warning about a diuretic cascade. Teaching, monitoring, a MedWatch report, practice lessons and the reasons not to rechallenge complete the record.
NR 568 Week 6 rubric: what full points look like
Adverse effect write-ups are typically assessed on a stated interval compared with known patterns, a check on dose relationship, a clear record of what was stopped, attention to the condition left untreated and a decision about reporting. Removing the drug without treating the underlying condition loses the most, so this sample starts amlodipine for the blood pressure in the same visit. Stating the six-week interval and comparing it with published patterns supports attribution. Showing that sodium was normal at the lower dose for two years confirms dose tracking. Continuing citalopram, rather than stopping both drugs, keeps causation clear. Reporting to MedWatch and adding a practice-wide sodium check show professional responsibility. Cohort studies on thiazides and antidepressants support the reasoning.
NR 568 Week 6 help: mistakes that cost points
The largest deduction in this assignment comes from stopping the suspected drug and never addressing what it was treating. Another frequent gap is an account with no timing, which makes attribution impossible to judge. Many write-ups list every possible cause at length instead of recording the interval and dose relationship. Some stop several drugs at once, losing the ability to identify the culprit. Others forget to say what the patient was told or whether the event should be reported. Fix the interval, check the dose relationship, record what came off and what replaced it, tell the patient and decide on reporting. A write-up for another reaction can be prepared from the timeline and laboratory results of your case.
Get a NR 568 Week 6 example written to your instructions
Send the Week 6 case as your classroom words it, along with the regimen and any required fields, and a custom example is written to that case and comes back inside 24-48h, free the first time. It records the timing, the dose relationship and the outcome of the removal, and it says what covered the condition afterwards.
More NR 568 papers and AGPCNP samples
- NR 568 Week 1: Citalopram Dose Discussion Post
- NR 568 Week 2: Medication List Review
- NR 568 Week 3: Clarithromycin Interaction Analysis
- NR 568 Week 4: Allopurinol in CKD Case Analysis
- NR 568 Week 5: Deprescribing Plan
- NR 568 Week 7: Polypharmacy Case Study
- NR 568 Week 8: Pharmacotherapy Synthesis
NR 568 Week 6 questions, answered
Is this the same as arguing what else could have caused it?
No, and that is the commonest way this document drifts off course. The differential belongs to other classrooms in the sequence. What this one records is the case for the agent, the action that followed and the outcome, with other explanations acknowledged in a line where they are genuinely live. A write-up spending half its length on alternative causes has usually run out of room for the part being graded.
Should the drug ever be given again to confirm it?
Almost never on purpose, and the write-up says as much rather than leaving the question hanging in the air. A repeat exposure risks the same harm for information that changes very little, and the situations where it is defensible are narrow and usually specialist. Where the patient resumed the agent themselves and the effect came back, record it, because that is the strongest evidence in the file and nobody chose it.
How is severity described?
In terms of what the patient could no longer do. A rating word tells a grader nothing and compares with nothing, while a sentence saying the person stopped driving, stopped sleeping through the night or came off the stairs carries the weight the response has to match. Severity written that way also explains why the action was urgent, or why it could reasonably wait for a planned review.
Where can I find a free NR 568 Week 6 sample paper?
The hyponatremia write-up above, which traces the confusion to a chlorthalidone increase and replaces it with amlodipine, is the full NR 568 Week 6 sample. Another reaction can be written up from your timeline.
Why is citalopram continued in the NR 568 Week 6 write-up?
Its dose had recently been lowered and the patient had taken it for years without low sodium, so the timing points to chlorthalidone; stopping both would hide the cause.